PPARG and cancer: Although PPARγ activators havebeen widely shown to inhibit growth in cultured cancer cells, in vivo effectshave proved to be complex: they inhibit but sometimes promote cancer growth [16] probably due to stimulation ofantiproliferative and apoptotic signaling pathways or proliferative andantiapoptotic pathways, depending on cellular conditions[3, 12, 15–18].